(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TARLEVO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TARLEVO

ST13

US500000079045266

Class

5

Filing

79045266

Registration

3534284

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

03/31/2017

Trademark type

Word

Nice classes

5

Filing date

09/19/2007

Registration date

11/18/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/19/2015

Last transaction

03/16/2016

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

CH

Examiner

SPILS, CAROL

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Actelion Pharmaceuticals Ltd
UCB PHARMA S.A.

Representatives

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationspreparations for the treatment of infectious diseasescancerophthalmologic conditions and diseasescentral nervous systems diseases and disordersParkinson's diseasecardiovascular diseases and conditionsmigrainesarthritispharmaceutical preparations for the treatment of gastrointestinal diseasesCrohns diseasepharmaceutical preparations for the treatment and symptoms of diabetespharmaceutical preparations for urological usepharmaceutical preparations for the treatment of urinary tract and bladder infectionsgynecological preparations for the treatment of birth controlfor the treatment for endometriosishormonal preparationshormone replacement therapy; analgesics; anti-inflammatory pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

33 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

03/31/2017

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

04/11/2016

INPC

INVALIDATION PROCESSED

04/11/2016

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

02/19/2016

C71T

CANCELLED SECTION 71

06/19/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/30/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/14/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/06/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/06/2012

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/11/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/13/2010

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/10/2009

FIMP

FINAL DISPOSITION PROCESSED

03/10/2009

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/18/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

11/18/2008

PUBO

PUBLISHED FOR OPPOSITION

09/02/2008

NPUB

NOTICE OF PUBLICATION

08/13/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/31/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/30/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/27/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/27/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

07/02/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/02/2008

ALIE

ASSIGNED TO LIE

07/02/2008

MAIL

PAPER RECEIVED

06/30/2008

RFNT

REFUSAL PROCESSED BY IB

01/24/2008

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/02/2008

RFRR

REFUSAL PROCESSED BY MPU

01/02/2008

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/31/2007

CNRT

NON-FINAL ACTION WRITTEN

12/30/2007

DOCK

ASSIGNED TO EXAMINER

12/22/2007

NWAP

NEW APPLICATION ENTERED

11/16/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/15/2007

Continuous trademark protection

Get notified about every new filing that threatens TARLEVO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.